Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

In this interview, News Medical speaks with Guillaume Bentzinger, Project Manager at Novalix; Luis Carrillo, Managing Director at De Dietrich France; Philippe Robin CEO of Alysophil; and Alejandro ...

Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...

The government has reopened the PLI scheme for bulk drugs, inviting fresh applications for meropenem and ritonavir to boost ...

Novo Nordisk (NVO) has pledged DKK 42B ($6B) from 2023 through the next six years to expand production capacity in its home country. The investment will go into ramping up production at existing ...

Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...